Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth

Healthcare Market Update - June 2017

Published last July Wednesday 5, 2017

Autonomous Driving - Sector Analysis

Published last June Tuesday 20, 2017

Healthcare Market Update - May 2017

Published last June Thursday 1, 2017

Upon pricing its landmark IPO on Euronext Paris led by Sole Global Coordinator Bryan, Garnier & Co, Symetis is acquired by Boston Scientific for USD 435 million

Having completed its IPO roadshow, closed books, and established the official IPO price, Symetis, the leading European structural heart player, received a definitive, all-cash offer from Boston Scientific to purchase the Company

Published last April Thursday 27, 2017

Receive Alerts

Enter your email to receive our news and offers.